Concepts (192)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Coumestrol | 2 | 2010 | 5 | 0.540 |
Why?
|
| DDT | 2 | 2010 | 15 | 0.530 |
Why?
|
| Oxides | 2 | 2014 | 100 | 0.470 |
Why?
|
| Diethylhexyl Phthalate | 1 | 2014 | 4 | 0.430 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2014 | 47 | 0.420 |
Why?
|
| Apoptosis | 9 | 2014 | 1568 | 0.410 |
Why?
|
| Calcium-Binding Proteins | 1 | 2014 | 81 | 0.410 |
Why?
|
| Environmental Pollutants | 2 | 2014 | 201 | 0.390 |
Why?
|
| Glioblastoma | 1 | 2014 | 74 | 0.390 |
Why?
|
| Brain Neoplasms | 1 | 2014 | 140 | 0.370 |
Why?
|
| Neoplasm Proteins | 1 | 2014 | 228 | 0.370 |
Why?
|
| Estrogens | 3 | 2010 | 203 | 0.310 |
Why?
|
| Caspases | 3 | 2008 | 148 | 0.300 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 2 | 2008 | 12 | 0.300 |
Why?
|
| Phospholipid Transfer Proteins | 1 | 2008 | 7 | 0.290 |
Why?
|
| Gene Expression Regulation | 3 | 2017 | 1070 | 0.260 |
Why?
|
| Mitochondria | 2 | 2008 | 523 | 0.260 |
Why?
|
| Interleukin-2 | 2 | 2004 | 91 | 0.250 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 6 | 2010 | 152 | 0.200 |
Why?
|
| Phenols | 1 | 2004 | 107 | 0.190 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2004 | 279 | 0.190 |
Why?
|
| Cell Cycle | 5 | 2010 | 346 | 0.180 |
Why?
|
| Jurkat Cells | 6 | 2008 | 87 | 0.170 |
Why?
|
| Arsenicals | 2 | 2014 | 87 | 0.170 |
Why?
|
| Estradiol | 4 | 2005 | 268 | 0.170 |
Why?
|
| Cell Line | 7 | 2017 | 1410 | 0.150 |
Why?
|
| Peroxiredoxins | 1 | 2017 | 11 | 0.130 |
Why?
|
| Cardiolipins | 2 | 2008 | 12 | 0.130 |
Why?
|
| RNA Interference | 1 | 2017 | 247 | 0.120 |
Why?
|
| Serine Endopeptidases | 1 | 2016 | 48 | 0.120 |
Why?
|
| Cell Proliferation | 2 | 2014 | 1455 | 0.120 |
Why?
|
| Oxidation-Reduction | 1 | 2017 | 457 | 0.120 |
Why?
|
| Humans | 19 | 2017 | 43102 | 0.110 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2016 | 67 | 0.110 |
Why?
|
| Lentivirus | 1 | 2014 | 24 | 0.110 |
Why?
|
| Blotting, Western | 5 | 2010 | 883 | 0.110 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2016 | 257 | 0.110 |
Why?
|
| Cell Movement | 2 | 2017 | 655 | 0.100 |
Why?
|
| DNA Damage | 2 | 2014 | 356 | 0.100 |
Why?
|
| Membrane Proteins | 2 | 2016 | 561 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 189 | 0.100 |
Why?
|
| Adenocarcinoma | 1 | 2016 | 291 | 0.100 |
Why?
|
| Gene Silencing | 1 | 2014 | 154 | 0.100 |
Why?
|
| Caspase 3 | 3 | 2010 | 227 | 0.100 |
Why?
|
| Pancreatic Neoplasms | 1 | 2016 | 218 | 0.100 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2014 | 165 | 0.100 |
Why?
|
| Cell Survival | 2 | 2014 | 945 | 0.100 |
Why?
|
| T-Lymphocytes | 3 | 2005 | 386 | 0.090 |
Why?
|
| Heme Oxygenase (Decyclizing) | 2 | 2001 | 31 | 0.090 |
Why?
|
| Hela Cells | 2 | 2010 | 376 | 0.090 |
Why?
|
| Protein Kinase C-delta | 2 | 2008 | 17 | 0.090 |
Why?
|
| MicroRNAs | 1 | 2017 | 518 | 0.080 |
Why?
|
| Models, Biological | 2 | 2017 | 712 | 0.080 |
Why?
|
| Enzyme Activation | 2 | 2008 | 462 | 0.080 |
Why?
|
| DNA Replication | 1 | 2010 | 148 | 0.080 |
Why?
|
| Cell Line, Tumor | 2 | 2014 | 2676 | 0.080 |
Why?
|
| Transfection | 2 | 2008 | 532 | 0.070 |
Why?
|
| Protein Binding | 3 | 2017 | 1082 | 0.070 |
Why?
|
| Recombinant Proteins | 2 | 2008 | 518 | 0.070 |
Why?
|
| Caspase 8 | 1 | 2008 | 32 | 0.070 |
Why?
|
| Membrane Lipids | 1 | 2008 | 30 | 0.070 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2008 | 186 | 0.070 |
Why?
|
| Progesterone | 3 | 2003 | 121 | 0.070 |
Why?
|
| DNA Primers | 1 | 2008 | 294 | 0.070 |
Why?
|
| Endocytosis | 1 | 2008 | 118 | 0.070 |
Why?
|
| Testosterone | 2 | 2005 | 211 | 0.060 |
Why?
|
| Base Sequence | 1 | 2008 | 983 | 0.060 |
Why?
|
| RNA, Messenger | 4 | 2004 | 1271 | 0.060 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 436 | 0.060 |
Why?
|
| Lymphocyte Activation | 2 | 2004 | 249 | 0.060 |
Why?
|
| Endostatins | 1 | 2005 | 5 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2005 | 384 | 0.060 |
Why?
|
| Lipopolysaccharides | 3 | 2003 | 239 | 0.060 |
Why?
|
| Ultraviolet Rays | 1 | 2005 | 118 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2010 | 495 | 0.050 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2005 | 161 | 0.050 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2004 | 20 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 224 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2016 | 968 | 0.050 |
Why?
|
| NF-kappa B | 2 | 2004 | 358 | 0.050 |
Why?
|
| Insecticides | 1 | 2004 | 54 | 0.050 |
Why?
|
| Benzhydryl Compounds | 1 | 2004 | 50 | 0.050 |
Why?
|
| Electromagnetic Fields | 1 | 2003 | 10 | 0.050 |
Why?
|
| Osteosarcoma | 1 | 2003 | 30 | 0.050 |
Why?
|
| Bone Neoplasms | 1 | 2003 | 49 | 0.050 |
Why?
|
| Tissue Preservation | 1 | 2001 | 7 | 0.050 |
Why?
|
| Hemin | 1 | 2001 | 7 | 0.050 |
Why?
|
| Cyclin A | 1 | 2001 | 4 | 0.050 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2001 | 34 | 0.040 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2001 | 32 | 0.040 |
Why?
|
| Sialoglycoproteins | 1 | 2001 | 14 | 0.040 |
Why?
|
| Cyclosporine | 1 | 2001 | 36 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2001 | 166 | 0.040 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2001 | 41 | 0.040 |
Why?
|
| Monocytes | 1 | 2003 | 277 | 0.040 |
Why?
|
| Vitamin E | 1 | 2001 | 62 | 0.040 |
Why?
|
| Kidney Tubules | 1 | 2001 | 39 | 0.040 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2001 | 55 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2001 | 189 | 0.040 |
Why?
|
| Transcription, Genetic | 2 | 2001 | 592 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2001 | 140 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2001 | 216 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2005 | 2157 | 0.040 |
Why?
|
| Kidney Diseases | 1 | 2001 | 172 | 0.040 |
Why?
|
| Cytokines | 2 | 2001 | 678 | 0.040 |
Why?
|
| Kidney | 1 | 2001 | 372 | 0.030 |
Why?
|
| Thymidine | 2 | 2010 | 15 | 0.030 |
Why?
|
| Antioxidants | 1 | 2001 | 443 | 0.030 |
Why?
|
| Macrophages | 1 | 2001 | 529 | 0.030 |
Why?
|
| Disulfides | 1 | 2017 | 95 | 0.030 |
Why?
|
| Carcinoma in Situ | 1 | 2016 | 16 | 0.030 |
Why?
|
| Protein Transport | 1 | 2017 | 296 | 0.030 |
Why?
|
| Binding Sites | 1 | 2017 | 671 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2017 | 526 | 0.030 |
Why?
|
| Disease Progression | 1 | 2016 | 667 | 0.020 |
Why?
|
| Prognosis | 1 | 2016 | 861 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 1067 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2005 | 220 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2016 | 1285 | 0.020 |
Why?
|
| DNA Fragmentation | 2 | 2003 | 98 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 2 | 2003 | 508 | 0.020 |
Why?
|
| Female | 2 | 2010 | 24698 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2016 | 449 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2017 | 1003 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 105 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2001 | 652 | 0.020 |
Why?
|
| Monensin | 1 | 2008 | 4 | 0.020 |
Why?
|
| Fas Ligand Protein | 1 | 2008 | 17 | 0.020 |
Why?
|
| Staurosporine | 1 | 2008 | 38 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2008 | 49 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2008 | 90 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2008 | 181 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2008 | 196 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2008 | 160 | 0.020 |
Why?
|
| Gene Expression | 2 | 2001 | 701 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2001 | 1621 | 0.020 |
Why?
|
| Time Factors | 2 | 2001 | 1857 | 0.020 |
Why?
|
| Phospholipases | 1 | 2005 | 7 | 0.010 |
Why?
|
| Diglycerides | 1 | 2005 | 9 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 2005 | 36 | 0.010 |
Why?
|
| Comet Assay | 1 | 2005 | 77 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2005 | 222 | 0.010 |
Why?
|
| Magnesium | 1 | 2005 | 94 | 0.010 |
Why?
|
| Receptors, Estradiol | 1 | 2003 | 2 | 0.010 |
Why?
|
| K562 Cells | 1 | 2003 | 32 | 0.010 |
Why?
|
| U937 Cells | 1 | 2003 | 31 | 0.010 |
Why?
|
| HL-60 Cells | 1 | 2003 | 33 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 263 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2005 | 456 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2003 | 114 | 0.010 |
Why?
|
| Proline | 1 | 2003 | 40 | 0.010 |
Why?
|
| Osteoblasts | 1 | 2003 | 44 | 0.010 |
Why?
|
| Receptors, Progesterone | 1 | 2003 | 92 | 0.010 |
Why?
|
| Reference Values | 1 | 2003 | 211 | 0.010 |
Why?
|
| Calcium | 1 | 2005 | 491 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 311 | 0.010 |
Why?
|
| Deferoxamine | 1 | 2001 | 17 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 2001 | 52 | 0.010 |
Why?
|
| RNA Probes | 1 | 2001 | 11 | 0.010 |
Why?
|
| Heme Oxygenase-1 | 1 | 2001 | 52 | 0.010 |
Why?
|
| Cold Temperature | 1 | 2001 | 40 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2001 | 64 | 0.010 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2001 | 60 | 0.010 |
Why?
|
| Ferritins | 1 | 2001 | 63 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 611 | 0.010 |
Why?
|
| Cell Size | 1 | 2001 | 46 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2001 | 132 | 0.010 |
Why?
|
| Culture Media | 1 | 2001 | 96 | 0.010 |
Why?
|
| Osteopontin | 1 | 2001 | 46 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2001 | 124 | 0.010 |
Why?
|
| Drug Resistance | 1 | 2001 | 96 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2001 | 152 | 0.010 |
Why?
|
| Kinetics | 1 | 2001 | 695 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2001 | 411 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2001 | 238 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2001 | 458 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2001 | 383 | 0.010 |
Why?
|
| Dactinomycin | 1 | 1998 | 11 | 0.010 |
Why?
|
| Receptors, Interleukin-1 | 1 | 1998 | 10 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1998 | 30 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 1998 | 39 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2001 | 1124 | 0.010 |
Why?
|
| Proteins | 1 | 2001 | 382 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2001 | 386 | 0.010 |
Why?
|
| Sex Factors | 1 | 2001 | 1028 | 0.010 |
Why?
|
| Pregnancy | 1 | 2003 | 1772 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2001 | 1766 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2001 | 1596 | 0.010 |
Why?
|
| Animals | 2 | 2001 | 16992 | 0.010 |
Why?
|
| Rats | 1 | 2001 | 3735 | 0.010 |
Why?
|
| Male | 2 | 2001 | 23409 | 0.010 |
Why?
|
| Mice | 1 | 2001 | 6644 | 0.000 |
Why?
|